Clinical trial · Observational
Underweight, Overweight, and Linear Growth of Childhood Cancer Patients - the Growth Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The Growth study investigates nutritional status, BMI, and linear growth trajectories from birth to adulthood in childhood cancer patients and survivors. Specifically, it aims to identify the predictors driving these distinct growth and weight trajectories and evaluate the consistency of these findings across multiple European countries. The study will make use of routine collected clinical data from oncology centres. Additional information about diagnoses, treatments, sociodemographic, and lifestyle data are obtained by linkages with disease and population registries, and with previously conducted questionnaire studies among survivors. The study will provide insights into the nutritional status of childhood cancer patients and survivors and improve understanding of growth patterns in this population.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Childhood Cancer | Childhood Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- Childhood cancer patients and survivors
- description
- Children diagnosed with cancer before age 20 between 2004-2026, who visited at a participating clinic in Switzerland, Portugal, or Slovenia
Primary outcomes (1)
- measure
- Body Mass Index z-score, Height z-score, Weight z-score
- timeFrame
- Through study completion, an expected average of 20 years
- description
- Body Mass Index calculated as weight in kg divided by height in meters, squared. z-scores calculated according to country-specific and international growth references. Height z-scores and weight z-scores calculated according to country-specific and international growth references.
Secondary outcomes (1)
- measure
- Risk factors associated with underweight, overweight, and impaired linear growth in childhood cancer patients and survivors
- timeFrame
- Through study completion, an expected average of 20 years
- description
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Diagnosed with cancer at age \<20 years * Diagnosed between 2004 and 2026 * Treated in one of the participating cancer centres: 1. Switzerland: patients who visited one of the cancer centres in Switzerland: Aarau, Basel, Bellinzona, Bern, Geneva, Lausanne, Lucerne, St. Gallen, Zurich. 2. Portugal: patients diagnosed between 2012-2026 at the Portuguese paediatric oncology centres Instituto Português de Oncologia do Porto Francisco Gentil - IPO-PORTO or at the Instituto Português de Oncologia Francisco Gentil - IPOLFG. 3. Slovenia: patients diagnosed between 2011-2026 at the paediatric oncology clinic University Medical Center Ljubljana.
References
Publications (0)
Data not yet available